Uganda Declares End to Sixth Ebola Outbreak

Uganda has officially declared the conclusion of its sixth Ebola virus outbreak, marking a significant milestone in the nation's health response. The outbreak, which began in late January, resulted in the death of at least two individuals and affected a total of 14 reported cases—12 confirmed and two probable—according to the World Health Organization (WHO). The confirmed cases involved the Sudan Ebola strain, including the death of a young child and a nurse. Throughout the outbreak, dozens of contacts were monitored to prevent further transmission.
The WHO reported that the outbreak was brought under control after 42 days had passed without any new confirmed cases, with the last patient being discharged on March 14, 2025. Uganda’s health authorities praised their team and the community for their effective response, facilitated in part by a rapid vaccination trial launched in February for the strain involved. This trial was notable as one of the fastest Ebola vaccine rollouts ever conducted during an ongoing epidemic.
The Ebola virus spreads primarily through contact with body fluids of infected individuals, with symptoms typically appearing after an incubation period of two to 21 days. While there is currently no approved vaccine for the Sudan strain, the ongoing vaccination efforts aim to contain future outbreaks.
The global health community continues to emphasize the importance of swift responses and adequate funding, especially as international aid has seen reductions following the US cessation of most humanitarian support. Past outbreaks have resulted in over 15,000 deaths in Africa across all six known Ebola strains.
World Health Organization Director Tedros Adhanom Ghebreyesus commended Uganda’s leadership and dedication in managing and ending this outbreak, underscoring the ongoing need for preparedness and international cooperation to combat Ebola.
Source: https://medicalxpress.com/news/2025-04-uganda-declares-6th-ebola-outbreak.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Key Mechanism Identified That Shields SARS-CoV-2 During Replication
Researchers have identified a vital mechanism that SARS-CoV-2 uses to protect its spike protein during replication, offering new targets for antiviral therapies and vaccine development.
Guidelines Recommend SGLT-2 and GLP-1 Therapies Primarily for Adults at Elevated Risk of Heart and Kidney Issues
New international guidelines recommend using SGLT-2 inhibitors and GLP-1 receptor agonists mainly for adults with type 2 diabetes at moderate or high risk of heart and kidney complications, supporting personalized treatment approaches.
Study Reveals How Aging of CAR-T Cells Contributes to Cancer Recurrence
Research from Mayo Clinic uncovers that aging of CAR-T cells contributes to cancer relapse, highlighting new pathways to improve therapy durability and effectiveness.
The Role of Education and Social Factors in Rheumatic and Musculoskeletal Diseases
Emerging research emphasizes the critical role of social determinants like income and education in shaping outcomes for patients with rheumatic and musculoskeletal diseases. Findings from the EULAR 2025 congress reveal how these factors influence disease progression and mortality, highlighting the need for targeted interventions to promote health equity.